Brain-assessment device innovator BrainScope, and Aon plc (NYSE: AON), a leading global professional services firm, today announced the completion of an intellectual property-based funding arrangement. The funding arrangement provides BrainScope with up to $35 million in capital to fund the full expansion of its commercial activities as well as to develop new clinical applications on its platform. “More than four million …
One in Three Women Die of Heart Disease in the US Every Year While still the number one cause of death in the U.S., according to the Centers for Disease Control, awareness has been dropping steadily over the past 10 years. Although it’s commonly thought of as a “man’s disease,” almost one American woman per minute …
Organon “envisions a better and healthier every day for every woman” by focusing on medical issues and targeted solutions impacting women. Today it’s a global healthcare company formed through a spinoff from Merck, and builds upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, …
A Pharma Powerhouse for Women – Organon – on Communicating About Healthcare READ MORE
Eli Lilly announced last month that the U.S. Food and Drug Administration (FDA) had approved its Verzenio (abemaciclib) for a specific type of early breast cancer that is at high risk of recurrence after surgery. The drug is limited to patients who test at least 20% for a Ki-67 score on an FDA-approved test. Ki-67 is a marker of cellular …
When it comes to women earning less than men, two researchers say, size matters. That is, the size of the teams they supervise early in their careers. Laura Kray and Margaret Lee of the University of California, Berkeley, have published a study of nearly 2,000 recent business-school graduates. They found a new piece of the …
Researchers at the Cleveland Clinic are set to launch the Phase I trial for what could be the first-ever vaccine to prevent triple-negative breast cancer. The decision to move forward with the trial comes on the heels of the U.S. Food and Drug Administration‘s approval of its Investigational New Drug (IND) application, allowing Cleveland Clinic and its partner, Anixa Biosciences, …
Trial For World’s First Potential Breast Cancer Vaccine Begins READ MORE
We do what no one else does. We show the breadth and depth of remarkable women leaders. They are real women - with life stories to share - successes and failures, highs and lows. Their stories will empower more women to discover, accomplish and share their business dreams and goals.
In each issue we dive into a specific business segment. This issue focuses on Healthcare - certainly front and center in our lives. Future issues will focus on Finance, Marketing, Technology, Entrepreneurship ... Skills are transferable and there's so much to learn from the businesswomen in every issue.
HERE is a special welcome from our Founder.
